ASP changes see more increases than decreases

Why This Topic Matters

Quarterly ASP updates can affect drug reimbursement under Medicare Part B, so practices that bill high-volume drugs need to monitor the overall direction of payment changes and identify items with notable swings.

Article Sections

1. Quarterly ASP update overview

   Introduces the fourth-quarter Medicare ASP update, the effective dates, and the overall pattern of increases, decreases, and unchanged pricing across the listed drugs.

2. Notable pricing volatility and high-volume examples

   Discusses several drugs with larger quarter-to-quarter payment swings and places the changes in the context of prior updates and billing volume.

3. Top billed drugs with a payment increase

   Presents a list of drugs with higher payments in the update, along with the reported price comparisons for the quarter.

4. Top billed drugs with a payment decrease

   Presents a list of drugs with lower payments in the update, along with the reported price comparisons for the quarter.

5. Source and methodology note

   Identifies the CMS ASP lists used for the analysis and explains the general selection criteria for the drugs included in the article.